ASH 2024 Summary: Highlights in Bone Marrow Failure Disorders

2024 ASH Annual Meeting Insights Hub

P. Scheinberg

Thrombosis in Patients With ITP

Platelet Disorder Support Association (PDSA)

H. Liebman

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

Misinformation in ITP

Platelet Disorder Support Association (PDSA)

D. Nugent

ASH 2024 Review: New Therapies in ITP

Cleveland Clinic Taussig Cancer Institute

A. Hubben

Current Treatment Guidelines for ITP: Individualized Therapy and Eme…

Irina Murakhovskaya

Withdrawal of Voxelotor: Implications for Clinical Practice in Sickl…

Akshat Jain

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Initial Approach and Considerations for Management of ITP

Nicoletta Machin

Is There a Role for Splenectomy in ITP?

Platelet Disorder Support Association (PDSA)

C. Kessler

Management of Treatment-Naive ITP Patients

Weill Cornell Medicine Oncology & Hematology

J. Bussel

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

PKD: Diagnosis, Treatment and Monitoring for Complications

Stanford Medicine

M. Chien

Identifying and Treating Iron Deficiency in Pregnancy

Steven Fein

Mitapivat in PKD: Results of the ACTIVATE Trial and Updated Treatmen…

Stefan Eber

Switching ITP Patients to Avatrombopag From Other TPO-RAs: When to D…

Keck School of Medicine of USC

H. Liebman

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz